Trade

Epigral share price

Balanced risk
  • 35%Low risk
  • 35%Moderate risk
  • 35%Balanced risk
  • 35%High risk
  • 35%Extreme risk
  • 1,005.00(-3.39%)
    February 11, 2026 12:44:00 PM IST
    • NSE
    • BSE
  • Vol : 34.29 K (NSE + BSE)
    Last 20 day avg : 80.23 K

Epigral is trading -3.39% lower at Rs 1,005.00 as compared to its last closing price. Epigral has been trading in the price range of 1,031.25 & 997.00. Epigral has given -14.76% in this year & 0.58% in the last 5 days. Epigral has TTM P/E ratio 15.57 as compared to the sector P/E of 25.21.There are 1 analysts who have initiated coverage on Epigral. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 39.11 Crores in its last quarter.Listed peers of Epigral include Coromandel International (0.18%), Asian Paints (0.02%), Solar Industries India (-0.17%).The Mutual Fund holding in Epigral was at 5.09% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Epigral was at 2.36% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Feb 11, 2026, 07:30 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.50
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.31
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.34
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.36
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    13.32
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.14
    Indicates Fair Valuation
Price range
Day Range
Lowest
997.00
Highest
1,031.25
52 week range
Lowest
903.10
Highest
2,114.30
Epigral Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Coromandel International
Bullish
2,272.000.1866,712.6239.156.370.505.40
Asian Paints
Bearish
2,395.000.022,29,732.6768.0113.770.907.13
Solar Industries India
Moderately Bullish
13,399.20-0.171,21,249.4390.2625.760.089.52
SRF
Neutral
2,927.10-1.1886,744.5573.187.270.2516.14
Pidilite Industries
Neutral
1,478.00-0.041,50,581.0870.1715.090.692.26
Mutual Fund Ownership
View all
HSBC Focused Fund Regular Growth
3/5
  • Amount Invested (Cr.) 44.62
  • % of AUM 2.68
HSBC Business Cycles Regular Growth
NA
  • Amount Invested (Cr.) 13.60
  • % of AUM 1.26
ITI Small Cap Fund Regular Growth
3/5
  • Amount Invested (Cr.) 25.90
  • % of AUM 1.03
Bandhan Business Cycle Fund Regular Growth
NA
  • Amount Invested (Cr.) 17.01
  • % of AUM 1.01
ITI Multi Cap Fund Regular Growth
2/5
  • Amount Invested (Cr.) 12.67
  • % of AUM 1.01
Epigral Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-01-30Quarterly Results
2025-11-10Quarterly Results
2025-08-02Quarterly Results & Fund Raising
2025-05-05Audited Results & Final Dividend
2025-01-27Quarterly Results & Interim Dividend
About the company Epigral
  • IndustryChemical Manufacturing
  • ISININE071N01016
  • BSE Code543332
  • NSE CodeMFL
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. The Company operates in a single segment, which primarily relates to the manufacturing of Chlor Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as, alumina, pharmaceuticals, textiles, agrochemicals, epoxy resins, paints and coatings, paper and pulp, PU foams, CPVC pipes and fittings, construction, refineries, soaps, detergents, and others.
  • Management Info
  • Maulik PatelChairman of the Board, Managing Director
  • Rakesh AgrawalChief Financial Officer
  • Gaurang TrivediCompliance Officer, Company Secretary
  • Kaushal SoparkarExecutive Director
Epigral Share Price FAQs

Epigral is trading at 1005.00 as on Wed Feb 11 2026 07:14:00. This is -3.39% lower as compared to its previous closing price of 1040.30.

The market capitalization of Epigral is 4388.86 Cr as on Wed Feb 11 2026 07:14:00.

The average broker rating on Epigral is Strong Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 0.00 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Epigral is 2114.30 whereas the 52 wk low is 903.10

Epigral can be analyzed on the following key metrics -

  • TTM P/E: 15.57
  • Sector P/E: 25.21
  • Dividend Yield: 0.34%
  • D/E ratio: -

Epigral reported a net profit of 357.69 Cr in 2025.

The Mutual Fund Shareholding was 5.09% at the end of 31 Dec 2025.